Chemours price target raised to $18 from $16 at RBC Capital

RBC Capital raised the firm’s price target on Chemours (CC) to $18 from $16 and keeps an Outperform rating on the shares as part of a broader research note previewing Q4 for Commodity Chemicals as part of a broader research note previewing Q4 for Commodity Chemicals. Higher raw material costs and slow demand in Europe/Asia remain near-term headwinds, but TiO2 margins should improve, the analyst tells investors in a research note. The phase-out of high-GWP Hydrofluorocarbon refrigerants over the next 10-20 years should sustain demand growth for low-GWP hydrofluoroolefins into cooling and refrigerant applications, RBC added.